The melatonin MT2 receptor is involved in the anti-apoptotic effects of melatonin in rats with type 2 diabetes mellitus

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYapislar, Hande
dc.contributor.authorHaciosmanoglu, Ebru
dc.contributor.authorSarioglu, Turkan
dc.contributor.authorEkmekcioglu, Cem
dc.date.accessioned2025-10-16T15:17:42Z
dc.date.issued2022
dc.identifier.doi10.1016/j.tice.2022.101763
dc.identifier.otherWOS:000798367200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6993
dc.publisherCHURCHILL LIVINGSTONE
dc.sourceTISSUE \& CELL
dc.subjectT2DM
dc.subjectApoptosis
dc.subjectMelatonin
dc.subjectMT2
dc.subjectLuzindole
dc.subjectExperimental diabetes mellitus
dc.titleThe melatonin MT2 receptor is involved in the anti-apoptotic effects of melatonin in rats with type 2 diabetes mellitus
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS